Procyon Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.31M | Sell |
|
|||||
|
2025
Q2 | $1.97M | Sell |
|
|||||
|
2025
Q1 | $9.02M | Buy |
|
|||||
|
2024
Q4 | $5.89M | Sell |
|
|||||
|
2024
Q3 | $6.98M | Buy |
|
|||||
|
2024
Q2 | $6.96M | Buy |
|
|||||
|
2024
Q1 | $5.99M | Buy |
|
|||||
|
2023
Q4 | $5.57M | Buy |
|
|||||
|
2023
Q3 | $4.43M | Buy |
|
|||||
|
2023
Q2 | $2.59M | Buy |
|
|||||
|
2023
Q1 | $1.05M | Buy |
|
|||||
|
2022
Q4 | $780K | Buy |
|
|||||
|
2022
Q3 | $370K | Sell |
|
|||||
|
2022
Q2 | $385K | Buy |
|
|||||
|
2022
Q1 | $347K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $79K | Hold |
|
|||||
|
2020
Q1 | $65K | Hold |
|
|||||
|
2019
Q4 | $60K | Buy |
|